Understanding how certain proteins help control gene activity and maintain DNA stability
Regulation of transcription termination by checkpoint kinases Mec1p and Rad53p
['FUNDING_R15'] · ST. JOHN'S UNIVERSITY · NIH-10729762
This study is looking at how certain proteins help control the end of gene reading in our cells, especially when there's DNA damage or stress, to keep our genes stable and healthy, which could help us understand more about cancer and improve treatments for patients.
Quick facts
| Phase | ['FUNDING_R15'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ST. JOHN'S UNIVERSITY (nih funded) |
| Locations | 1 site (QUEENS, UNITED STATES) |
| Trial ID | NIH-10729762 on ClinicalTrials.gov |
What this research studies
This research investigates the role of checkpoint kinases Mec1p and Rad53p in regulating the process of transcription termination, which is crucial for maintaining genome stability. By examining how these proteins respond to DNA damage and replication stress, the study aims to uncover mechanisms that prevent interference between transcription and DNA replication. The approach involves analyzing the behavior of RNA polymerase II at gene ends and how its accumulation can lead to genomic instability when checkpoint functions are compromised. Patients may benefit from insights gained into how these processes affect cancer development and treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cancers that may be influenced by DNA damage and repair mechanisms.
Not a fit: Patients with non-malignant conditions or those whose cancers are not related to DNA damage responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for improving cancer treatments by enhancing our understanding of DNA damage responses.
How similar studies have performed: Other research has shown promising results in understanding DNA damage responses, indicating that this approach has potential for significant findings.
Where this research is happening
QUEENS, UNITED STATES
- ST. JOHN'S UNIVERSITY — QUEENS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VANCURA, ALES — ST. JOHN'S UNIVERSITY
- Study coordinator: VANCURA, ALES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer, DNA Injury